Skip to main content

SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research

In brief

A 41-study review sets molecular testing guidance for pediatric solid tumors

A multidisciplinary group used 41 studies and expert consensus to recommend when children with solid tumors should receive DNA and RNA sequencing and methylation profiling, both at diagnosis and at relapse. The guidelines offer a framework to standardize testing, but whether broad adoption improves diagnosis or access to targeted treatment remains to be shown.

Journal
Clinical cancer research : an official journal of the American Association for Cancer Research (Q1)
Published
11 November 2026
Study design
Practice guideline / consensus
Evidence level
Level 1, High (CEBM 1c)
Authors
Catherine Gestrich, Larissa V Furtado, Jaclyn Biegel, Maryam Fouladi, Andrew L Kung, Theodore W Laetsch, et al.
PMID
43013345
DOI
10.1158/1078-0432.CCR-26-1643

Why clinicians should know about it

  • Picked for Oncology and Radiation Oncology (top studies of the week, 15 November 2026): Guideline, molecular profiling recommendations for pediatric solid tumors

Abstract

PURPOSE: Molecular diagnostics are standard of care for most adults with solid malignancies, but implementation in pediatric solid tumors remains inconsistent. The SPROUT (Somatic Profiling for Pediatric Cancer Refining our Understanding and Treatment) Molecular Guidelines Working Group was convened to develop molecular testing guidelines for pediatric solid tumors. EXPERIMENTAL DESIGN: A structured literature review was performed using Covidence to identify relevant clinical studies evaluating molecular diagnostics in pediatric solid tumors. The literature and collective clinical experience of the multidisciplinary working group were used to develop consensus recommendations for molecular profiling at diagnosis and at relapse or recurrence. RESULTS: Of 361 manuscripts screened, 41 studies were included for data extraction. Based on the available evidence and expert consensus, recommendations were developed for the use and timing of DNA and RNA next-generation sequencing and methylation profiling across pediatric solid tumors. CONCLUSIONS: The SPROUT Molecular Guidelines provide a framework for standardized implementation of molecular diagnostics in pediatric solid tumors. Broad adoption of these recommendations may improve diagnostic precision, reduce variability in molecular testing, and increase opportunities for biomarker-directed therapy and clinical trial enrollment for children with cancer.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.